Ignite Creation Date:
2024-05-05 @ 10:21 PM
Last Modification Date:
2024-10-26 @ 10:17 AM
Study NCT ID:
NCT01089582
Status:
COMPLETED
Last Update Posted:
2011-04-28
First Post:
2010-03-17
Brief Title:
Quality Of Life Assessment In Alzheimers Disease AD Patients Receiving Aricept Tablets
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Quality Of Life Assessment In AD Patients Receiving Aricept Tablets Donepezil Hydrochloride
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
QUEST
Brief Summary:
This study assessed the Hr QoL Health related Quality of life of subjects with mild to moderate AD who received ARICEPT under usual clinical practice
Detailed Description:
This non-interventional study enrolled patients with mild to moderate dementia of the Alzheimers type who have been prescribed treatment with ARICEPT under usual clinical practice
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None